Literature DB >> 1099254

Letter: Treatment of spasticity in multiple sclerosis with dantrolene.

E S Tolosa, R W Soll, R B Loewenson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1099254

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

Review 1.  Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546

Review 2.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

Review 3.  Drugs used to treat spasticity.

Authors:  M Kita; D E Goodkin
Journal:  Drugs       Date:  2000-03       Impact factor: 11.431
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.